ASTM E2500-13
制藥和生物制藥生產系統和設備的規范, 設計與驗證的標準指南
Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
ASTM E2500-13 中，可能用到以下耗材
- 標準號
- ASTM E2500-13
- 發布
- 2013年
- 發布單位
- 美國材料與試驗協會
- 替代標準
- ASTM E2500-20
- 當前最新
- ASTM E2500-20
- 引用標準
- ASTM E2363 ASTM E2474 ASTM E2475 ASTM E2476 ASTM E2537 ASTM E2629
- 適用范圍
5.1x00a0;Application of the approach described within this guide is intended to satisfy international regulatory expectations in ensuring that manufacturing systems and equipment are fit for intended use, and to satisfy requirements for design, installation, operation, and performance.
5.2x00a0;The approach described in this guide applies concepts and principles introduced in the FDA initiative, Pharmaceutical cGMPs for the 21st Centuryx2014;A Risk-Based Approach.
5.3x00a0;This guide supports, and is consistent with, the framework described in ICH Q8, ICH Q9, ICH Q10, and ICH Q11.
5.4x00a0;This guide may be used independently or in conjunction with other E55 standards published by ASTM International.
1.1x00a0;This guide is applicable to all elements of pharmaceutical and biopharmaceutical manufacturing systems including: facility equipment, process equipment, supporting utilities, associated process monitoring and control systems, and automation systems that have the potential to affect product quality and patient safety.
1.2x00a0;For brevity, these are referred to throughout the rest of this guide as manufacturing systems.
1.3x00a0;This guide may also be applied to laboratory, information, and medical device manufacturing systems.
1.4x00a0;This guide is applicable to both new and existing manufacturing systems. The approach may be used for the implementation of changes to existing systems, and their continuous improvement during operation.
1.5x00a0;This guide is applicable throughout the life-cycle of the manufacturing system from concept to retirement.
1.6x00a0;This standard does not address employee health and safety, environmental, or other non-GxP regulations. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
ASTM E2500-13相似標準
推薦
2019中國國際生物制藥4.0峰會將于三月開幕
工業4.0和生物制藥連續生產 全球一次性概念和可重組模塊化工廠設計的關鍵因素 傳統不銹鋼設備與一次性系統的成本效率對比 “一次性使用系統”浸出物和可提取物研究及本土化驗證服務 AI，集成數據，虛擬建模完善生物制造工藝與質量控制 QbD的DoE策略 (分會場B) 最新合同外包模式及生物制藥研發： MAH制度下的合同生產的商業模式的探討 藥企應采取哪些關鍵方法來與外部供應鏈網絡的更好融合...
2020制藥環保與潔凈技術展邀您暢游潔凈新世界
生物潔凈技術論壇 國內&歐美生物制藥潔凈材料工藝創新及新技術動向，多位資深知名專家一對一交流機會 潔凈廠房設計、驗證與項目管理培訓 潔凈室項目管理全過程的相關法規、指南、檢查指導、達標方針等標準及新廠建設實操講解 醫藥潔凈領域設計與工程創新論壇 醫藥工業潔凈廠房設計標準關鍵起草人宣講，權威答疑互動 工廠參觀——“潔凈室系統解決方案”線路 趣味與實用相結合，親身體驗供應商的制造技術...
馬爾文發布新型量熱計MicroCal PEAQ-DSC
我們與上一代DSC系統的用戶密切合作，確保MicroCal PEAQ-DSC在生物制藥開發周期中支持廣泛的需求。隨著生物制藥的重要性不斷增長，我們看到客戶正在尋找強大的分析系統，可以提供真正為開發，制定和過程決策提供信息的數據，以及支持監管挑戰。 DSC長期以來一直被認為是穩定性測量的黃金標準，但現在，使用新的MicroCal PEAQ-DSC，我們相信我們已經重新定義了這種技術的可能性。”...